JPS6185324A - Production of carcino static agent - Google Patents

Production of carcino static agent

Info

Publication number
JPS6185324A
JPS6185324A JP59207038A JP20703884A JPS6185324A JP S6185324 A JPS6185324 A JP S6185324A JP 59207038 A JP59207038 A JP 59207038A JP 20703884 A JP20703884 A JP 20703884A JP S6185324 A JPS6185324 A JP S6185324A
Authority
JP
Japan
Prior art keywords
fruit
native
var
crocosmia
plach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59207038A
Other languages
Japanese (ja)
Inventor
Satoshi Sasaki
佐々木 ▲さとし▼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP59207038A priority Critical patent/JPS6185324A/en
Publication of JPS6185324A publication Critical patent/JPS6185324A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a carcinostatic agent from a water extracted solution of a dried substance of it, by using Sophorae subprostratae radix and Crocosmia aurea Plach. as bases, and blending them with fruit of Opuntia Ficus-indica Mill. var. Cacti to give the water extracted solution. CONSTITUTION:Sophorae subprostratae radix(plant belonging to the genus Sophora of Leguminosae) and Crocosmia aurea Plach(perennial root native to South Africa having about 1m height) are used as bases, and blended with Opuntia Ficus-indica Mill. var. Cacti(perennial rot native to Mexico, having stalk reaching 2m, elliptic, flat, and thick stem node) fruit, or Pseudocydonia sinensis Schneid(deciduous tall tree native to China) fruit, Trapa natans L. var. bispinosa(annual root growing in pond or swamp) fruit, and Panax Schinseng Nees(perennial root native to China and Korea) to give a water extracted solution of the blend or a dried substance of it. A carcinostatic agent containing the water aqueous solution or the dried substance of it as an active ingredient. Combination of each component provides synergistic effect.

Description

【発明の詳細な説明】 本発明は、 (1)  山豆根とヒオオギスイセンを基材とし、これ
にサボテンの実を加えたものの水抽出液又はその乾燥物
よりなる抗癌剤の製造法 (2)  上記の基材にカリシの実、0・しの実、苦参
(薬用人参)を加えたものの水抽出液又はその乾燥物よ
り成る抗癌剤の製造法の発明である。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides: (1) A method for producing an anticancer agent consisting of an aqueous extract or a dried product of a product obtained by adding cactus fruits to wild bean root and narcissus as base materials (2) ) This invention is an invention of a method for producing an anticancer agent comprising an aqueous extract of the above base material to which cauliflower seeds, white nuts, and bitter ginseng (medicinal ginseng) are added or a dried product thereof.

本発明で使用する山豆根は、マメ科5ophora属の
植物であって、現在主と(7て中国から輸入されており
、苗蔓が豆様のような形状をなしている。
The wild bean root used in the present invention is a plant belonging to the Fabaceae family, genus Ophora, and is currently mainly imported from China, and its seedlings have a bean-like shape.

ヒオオギスイセン(Crocosmia aurea 
Plach)は、高さ1メートル前後をなす南アフリカ
原産の多年生草本である。
Crocosmia aurea
Plach is a perennial herb that grows around 1 meter in height and is native to South Africa.

サボテン(0puntia Ficus−indica
 MilivarSaboten)は、メキシコ原産の
多年生草本であって茎は高さ2メートルに達し、楕円形
で偏平、肥厚した茎節を有することを特徴とする。
Cactus (0puntia Ficus-indica)
Milivar Saboten) is a perennial herb native to Mexico, and its stems reach a height of 2 meters, and are characterized by having oval, oblate, and thickened stem nodes.

カリシ(Pseudocydonia 5inensi
s Schneid)は、高さ8メ′川・ル位に達する
中国原産の落葉高木で、その実は長さ10cmの大きな
f! 「■l形をなし、果肉はかたい。
Pseudocydonia 5inensi (Pseudocydonia 5inensi)
Schneid) is a deciduous tree native to China that reaches a height of 8 meters, and its fruit is a large f! ``■The fruit is l-shaped and has hard flesh.

ひしくTrapa natans 1.、var、B1
5pinosa )は、池沼にはえる一年生II+(本
であって、その実にはトゲがある。
Trapa natans 1. ,var,B1
5pinosa) is a book that grows in ponds and swamps, and its fruit has thorns.

苦参(薬用人参)  (Panax Schinsen
g Neeslは、中国お、Lび朝鮮原産の多年生草本
て高さ60 cm程度の薬用植物である。
Panax Schinsen (Medicinal ginseng)
Neesl is a perennial herb and medicinal plant with a height of about 60 cm that is native to China, Korea, and Korea.

実施例1 111豆根(全草を1二1置・たもの)10gヒオオギ
スイセン      30B −1ナボテン           40gを水抽出(
)て、抽出11に500m1を得た。
Example 1 10g of 111 bean root (whole plant placed in 121 places) 40g of Daffodil 30B-1 Naboten was extracted with water (
) to obtain 500 ml of extraction 11.

このうち100 mlを凍結乾燥することに」、す、乾
燥エキス0.8550gを得た。
100 ml of this was freeze-dried to obtain 0.8550 g of dried extract.

実施例2 山豆根(全草を1干したもの)10g ヒAオギスイセン      25g カリン          10g ひじの実           10g人   参  
                8gを水抽出して、
抽出液600 mlを得た。
Example 2 Yama bean root (1 dried whole plant) 10g Daffodil 25g Karin 10g Elbow fruit 10g Carrot
Extract 8g with water,
600 ml of extract was obtained.

乙のうち75IIIlを凍結乾燥することにJす、乾燥
エキス1.0870 gを得た。
Of the total, 75III was freeze-dried to obtain 1.0870 g of dried extract.

本願の方法による発明品の抗癌作用を次のように試験し
作用効果を確認した。
The anticancer effect of the invention product according to the method of the present application was tested as follows, and the effect was confirmed.

以下特許請求の範囲第1項にJ、って得た抽出液をVR
−3、同第2項によって得を1抽出液をV R−Hと略
称する。
The extract obtained by J in claim 1 below is VR.
-3, the extract obtained according to the second paragraph is abbreviated as V R-H.

実験動物には、ICR−3l)[5週令マウス(浜松実
験動物協同組合より購入)、IT!¥5匹づつを使用し
た。
Experimental animals include ICR-3l) [5-week-old mice (purchased from Hamamatsu Experimental Animal Cooperative), IT! I used ¥5 each.

各マ・クスに稙継後、7日月のサルコーマ180腹水か
ら2.5X]0’ケ/n11の細胞浮遊液を調整したも
の0.2ml (5X 105ケ)をlllff2内に
接種し、24時間後から−)=記薬物溶液を01m1又
は02mlづツ] El 1回11M腔内に注9・1シ
、711間で段りを中11−シ、以後の生死を観察しl
こ。
After incubation in each macus, 0.2ml (5x 105 cells) of a cell suspension prepared from 7 days old Sarcoma 180 ascites at 2.5 After 1 hour, pour 01 ml or 02 ml of the drug solution into the 11M cavity once, insert a step between 711 and 11, and observe whether the patient is alive or dead.
child.

飼料は固形飼料(Aリエンタル酵母株式会拐製)を使用
17、水は常水を自由に摂取させtこ。
The feed used was solid feed (manufactured by A Riental Yeast Co., Ltd.)17, and water was provided ad libitum.

比較実験 対照11Y(無段’J I!Y )は19日以内に全部
死亡し、平均生存11数は128±44日であった。
All of the comparative experiment control 11Y (Mudan'J I!Y) died within 19 days, and the average number of survivors was 128±44 days.

V R−11凍結乾燥エキス2 mg/ 0 、2 m
ll生食/マウス日日71]投与群ては平均生存日数3
94±231日でありT/C%307.8の極めて優れ
た延命効果が得られた。しかも60日生存マウス2匹の
創見の結果、腹水の貯留、固形腫瘍の存在は全く認めら
れず、内臓i!#器官に肉眼的変化は全く認められたな
かった。
VR-11 freeze-dried extract 2 mg/0, 2 m
The average survival time for the administration group was 3 days.
The survival time was 94±231 days, and an extremely excellent life-prolonging effect was obtained with a T/C% of 307.8. Moreover, the results of the examination of the two mice that survived for 60 days showed no accumulation of ascites or the presence of solid tumors, and internal organs i! #No macroscopic changes were observed in the organs.

VR−3凍結乾燥エキスl 、 5 u口10.2++
+1生食/マウス/日、7日投与群では平均生存日数2
8.6±9[1でありT/C%223.4日の統計的に
有意な延命効果が認められたが、60日間の生存マウス
はいなかった。
VR-3 freeze-dried extract l, 5 u mouth 10.2++
+1 saline/mouse/day, average survival days 2 in the 7-day treatment group
Although a statistically significant survival effect of 8.6±9 [1 and T/C% of 223.4 days was observed, no mice survived for 60 days.

上記の様に本発明の製品は動物実験の結果抗癌剤として
顕著な結果を秦する事を確認しlこ。
As mentioned above, animal experiments have confirmed that the product of the present invention has shown remarkable results as an anticancer agent.

尚、山豆根メタノール可溶部(アルカロイド画分)  
1mg10.2ml生食マウス/l’l、7日間投与群
では平均生存口数14.2士26FI、T/’C%11
0.9であり、銃創的に有意な延命効果は認められなか
った。
In addition, the methanol-soluble part of wild bean root (alkaloid fraction)
In the 1 mg 10.2 ml saline mouse/l'l, 7-day administration group, the average number of surviving mice was 14.2 26 FI, T/'C% 11
0.9, and no significant survival effect was observed for gunshot wounds.

山豆根メタノール可溶部(アルカロイド両分)  0.
5mg/ 0.1 ml生食/マウス/「1.7日間投
与群では、平均生存日数29.4±22.5日でありT
/C%229,8.60 F1間生存マウス(1匹)の
創見の結果は正常であっtコが、統計的に有意な延命効
果とは認められない。
Mountain bean root methanol soluble part (both alkaloid parts) 0.
In the 5 mg/0.1 ml saline/mouse/1.7-day administration group, the average survival time was 29.4 ± 22.5 days, and T
/C%229,8.60 Although the wound findings of one mouse surviving during F1 were normal, no statistically significant survival effect was observed.

山豆根メタノール不溶部(非アルカロイド画分)  2
mg/ 0 、2ml生食/マウス/日、7日間投与群
では、平均生存日数31.0±17.1E+、17C%
242.2であり、統諜l的にも有意のすぐ′i]た延
命効果を示したが、60日間生存マウス(1匹)には著
量の血液を混した腹水と収腔内にそら豆大の固形腫瘍が
認めらオlた。
Mountain bean root methanol insoluble part (non-alkaloid fraction) 2
mg/0, 2ml saline/mouse/day, 7 days administration group, mean survival days 31.0±17.1E+, 17C%
242.2, which showed a very significant survival effect, but one mouse that survived for 60 days had ascites mixed with a significant amount of blood and fava beans in the aperture. A large solid tumor was detected.

苦参XAr)−2吸着エタノール溶出画分(アルカ[I
イド両分1 1mg/ 0.2ml生食/マウス/「1
.7]−1間段句群では、平均生存日数23.2±20
.6日、T/C%18]、3と高かっlコが、銃創的に
は有意性が認められず、60[1間生存マウス(1匹)
(創見結果正常)を除いては14.0±1.6日T/C
%109゜4と全く無効であっtこ。
Bittersweet XAr)-2 adsorbed ethanol elution fraction (alka[I
1mg/0.2ml saline/mouse/1
.. 7] -1 stage group, mean survival days 23.2 ± 20
.. On day 6, T/C% was as high as 18] and 3, but no significant difference was observed in the gunshot wound, and 1 mouse survived for 60[1].
14.0±1.6 days T/C except for (normal finding results)
%109゜4, which is completely invalid.

苦参X A l) −2吸着エタノール溶出画分(アル
カロイド1ijI1分)  0.5m3/ O,1II
Il生食/マウス/日、7 E1間投与群では、平均生
存日数14.0±1.411.176%107.4で全
く無効であった。
Bitter Ginseng
In the group administered with Il saline/mouse/day for 7 E1, the effect was completely ineffective with an average survival time of 14.0±1.411.176%107.4.

苦参XAD−2通過水浸液凍結乾燥エキス(非アルカロ
イド画分)2mg10.2ml生食/マウス/日、7日
間投与群では、平均生存日数46.2±18.5日、T
/C%360.9と極めて高い値を示し統言1的に有意
の延命効果と認められるが、60日生存マウス2匹には
いれも巨大な固形腫瘍が認められた。
In the 7-day treatment group, the average survival time was 46.2 ± 18.5 days, T
/C%, which was an extremely high value of 360.9, and was recognized as having a significant survival effect according to syntax 1, but giant solid tumors were observed in two mice that survived for 60 days.

苦参XAD−2通水浸液凍結乾燥エキス(非アルカロイ
ド画分)  1 mg/ 0.1 mll生食/マウス
日日7日間投与1(Yでは、平均生存日数38.2±2
1.4日、170%298.4という統計的に有意な延
命効果が認められ、しかも60日生存マウスの創見でも
異常は発見されなかった。
Panax ginseng
A statistically significant survival effect of 1.4 days and 170% 298.4 days was observed, and no abnormality was found in the wounds of mice that survived for 60 days.

マイトマインソーC(MMC)  0 、02 mg/
マウス/日、7日間投与BYでは、平均生存日数50.
3−1=11.8[3、’r/C%392.2と最も高
い値を示し極めてずぐれた延命効果がみとめられた。し
かし60日生存マウス2匹中の1匹には血液を含む大量
の腹水と大きな固形腫瘍がみとめられた。他の1匹は正
常であった。
Might Mine So C (MMC) 0,02 mg/
When mice were administered for 7 days per day, the average survival time was 50.
3-1=11.8[3,'r/C% showed the highest value of 392.2, indicating an extremely excellent life prolonging effect. However, one of the two mice that survived for 60 days had a large amount of ascites containing blood and a large solid tumor. The other one was normal.

以」二の比較実験結果により、本発明の製造方法によっ
て得られtこVR−H,VR−3いずれの複合生薬水抽
出エキスにもマウス腹水癌に対するすぐれた延命効果が
認められ、それは本発明の構成成分である山豆根、苦参
単独の抽出液に比しても顕著な効果を有するものであっ
た。
The results of the following two comparative experiments show that both VR-H and VR-3 complex herbal medicine aqueous extracts obtained by the production method of the present invention have an excellent survival effect on ascites cancer in mice, which is due to the present invention. It had a remarkable effect compared to extracts of wild bean root and bitter ginseng, which are the constituent components of ginseng.

Claims (2)

【特許請求の範囲】[Claims] (1)山豆根(Sophora属)とヒオオギスイセン
(Crocosmia aurea Plach.)を
基材とし、これにサボテン(Opuntia Ficu
s−indica Mill.var.Saboten
)の実を加えたものの水抽出液又はその乾燥物より成る
抗癌剤の製造法
(1) The base material is wild bean root (Sophora genus) and daffodil (Crocosmia aurea Plach.), and cactus (Opuntia ficu) is used as the base material.
s-indica Mill. var. Saboten
) fruit added to the aqueous extract or its dried product.
(2)山豆根(Sophora属)とヒオオギスイセン
(Crocosmia aurea Plach.)を
基材とし、これにカリン(Pseudocydonia
 sinensis Schneid)の実、ひし(T
rapa natans L.var.bispino
sa)の実、苦参(薬用人参)(Panax Schi
nseng Nees)を加えたものの水抽出液又は其
の乾燥物より成る抗癌剤の製造法
(2) The base materials are wild bean root (Sophora genus) and Crocosmia aurea Plach.
sinensis Schneid) fruits, caltrops (T.
rapa natans L. var. bispino
sa) fruit, bitter ginseng (Panax Schi)
A method for producing an anticancer agent comprising an aqueous extract or a dried product thereof to which nseng nees) has been added.
JP59207038A 1984-10-04 1984-10-04 Production of carcino static agent Pending JPS6185324A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59207038A JPS6185324A (en) 1984-10-04 1984-10-04 Production of carcino static agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59207038A JPS6185324A (en) 1984-10-04 1984-10-04 Production of carcino static agent

Publications (1)

Publication Number Publication Date
JPS6185324A true JPS6185324A (en) 1986-04-30

Family

ID=16533174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59207038A Pending JPS6185324A (en) 1984-10-04 1984-10-04 Production of carcino static agent

Country Status (1)

Country Link
JP (1) JPS6185324A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538731A (en) * 1992-04-24 1996-07-23 Mikimoto Pharmaceutical Co., Ltd. Cosmetic
WO2000064279A1 (en) * 1999-04-23 2000-11-02 E Excel International Inc. Cactus fruit health products
US6210738B1 (en) 1999-04-23 2001-04-03 E Excel Internatioanal Inc. Freeze-dried ginseng berry tea
US6238672B1 (en) 1999-04-23 2001-05-29 E. Excel International Inc. Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
JP2001247460A (en) * 2000-03-07 2001-09-11 Univ Showa Apoptosis inducer
US6524626B2 (en) 1999-04-23 2003-02-25 E Excel International, Inc. Ginseng berry topical products
WO2003037324A1 (en) * 2001-10-29 2003-05-08 Korea Institute Of Science And Technology Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
US6576286B1 (en) 1999-04-23 2003-06-10 E Excel International Cactus fruit drinks and food products
US6737086B2 (en) * 1996-12-27 2004-05-18 Inovat S.A.R.L. Biologically active substances, method for obtaining and compositions containing them

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538731A (en) * 1992-04-24 1996-07-23 Mikimoto Pharmaceutical Co., Ltd. Cosmetic
US6737086B2 (en) * 1996-12-27 2004-05-18 Inovat S.A.R.L. Biologically active substances, method for obtaining and compositions containing them
WO2000064279A1 (en) * 1999-04-23 2000-11-02 E Excel International Inc. Cactus fruit health products
US6210738B1 (en) 1999-04-23 2001-04-03 E Excel Internatioanal Inc. Freeze-dried ginseng berry tea
US6238672B1 (en) 1999-04-23 2001-05-29 E. Excel International Inc. Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
US6524626B2 (en) 1999-04-23 2003-02-25 E Excel International, Inc. Ginseng berry topical products
US6576286B1 (en) 1999-04-23 2003-06-10 E Excel International Cactus fruit drinks and food products
JP2001247460A (en) * 2000-03-07 2001-09-11 Univ Showa Apoptosis inducer
WO2003037324A1 (en) * 2001-10-29 2003-05-08 Korea Institute Of Science And Technology Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
US7563467B2 (en) 2001-10-29 2009-07-21 Korea Institute Of Science And Technology Use of an Opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells

Similar Documents

Publication Publication Date Title
Van Wyk et al. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae)
US5589182A (en) Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
Pawar et al. Uses of Cassia fistula Linn as a medicinal plant
Li et al. 1. GINSENG
CN110519997A (en) Pass through the antibiosis of moringa oleifera leaf extractive and the compound of eucommia ulmoides extracts, anti-oxidant, anti-inflammatory, inhibition periodontal bone lesion and the method for regenerating periodontal bone alleviation gingivitis and periodontitis
Meher et al. Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its pharmacological evidences
KR101947786B1 (en) Food Composition for Stress Relaxation, Fatigue Recovery or Athletic Performance Enhancement Comprising Extract of herb
JPS6185324A (en) Production of carcino static agent
Yaneva et al. Some endangered healings plants in Bulgaria legislative regulation, protection, characteristic description, application, agricultural cultivation.
Nduche et al. Phytochemical screening and antimicrobial activity of Talinium triangulare (JACQ) Willd, Ocimum gratissimum L., Chromoleana odorata L., and Aloe vera (L.) Burm. F
Kartsev et al. Chemical composition and pharmacological properties of plants of the genus Stachys
KR0160108B1 (en) Anticancer agent of raw ingredient extracted from the tree named gleditschia officinalis
CN110585233B (en) Antitumor composition and pharmaceutical application thereof
CA2075077C (en) Stevia extract-containing liquid internal medicine and method of preparing the same
TWI811478B (en) Preparation method and pharmaceutical composition for the extract and composition of antrodia cinnamomea.
CN107519327A (en) A kind of Phellinus Chinese medicine composition and its extracting method and the application in antineoplastic is prepared
Rashid Detection of insulin-like protein and some active compounds in Bauhinia variegata Linn. leaf ethanolic extracts and the effect in reducing blood glucose levels in Mice
KR101846493B1 (en) Anti-inflammatory composition comprising phyto-extract mixture and composition for treatment of inflammatory diseases comprising the same
CN100427099C (en) Juglans mandshurica maxim pdysaccharide preparation capable of effectively treating brain cancer and its preapring method
CN113318137B (en) Preparation method of water-soluble acanthopanax powder capsule
KR101885648B1 (en) Composition comprising an extract of Cynanchi wilfordii, Polygonatum falcatum A. Gray, Petasites japonicas and Laminaria japonica for preventing or treating of stomach cancer
CN109758493B (en) Application of cardamine hirsute and extract thereof in preparation of drugs for preventing or treating arrhythmia
CN109568496B (en) Detection method of traditional Chinese medicine composition for treating diabetes
RU2377008C2 (en) Anticancer drug
KR20180052790A (en) Composition for control of statin side effect with extract of Pinellia ternata, Atractylodes macrocephala, Gastrodia elata, Citrus unshiu peel, Poria cocos, Crataegus pinnatifida, Siegesbeckia pubescens Makino and Coptis japonica Makino